These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 13626731)

  • 21. [The treatment of hemolytic disease of the newborn. Apropos of 196 infants treated by the team of the regional blood transfusion center].
    GOUDEMAND M; CAUDRELIER JR
    Pediatrie; 1960; 15():86-7. PubMed ID: 13828559
    [No Abstract]   [Full Text] [Related]  

  • 22. [Discovery of maternal isoimmunization and the study of the hemolytic disease of the newborn at the Saint-Pierre University hospital (Pr. J. Snoeck)].
    HUBINONT PO; BOUTE M; WILKIN P; BLACKMAN JH
    Bull Fed Soc Gynecol Obstet Lang Fr; 1952; 4(1):27-9. PubMed ID: 14954230
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of haemolytic disease of the newborn due to Rhimmunization.
    JOUVENCEAUX A; BRIZARD CP; MICHAUD D; REVOL L
    Br Med J; 1959 Sep; 2(5148):336-41. PubMed ID: 14407999
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cortisone in maternal isoimmunization in hemolytic disease of the newborn].
    GARZON HL
    Rev Belg Pathol Med Exp; 1955 Apr; 24(4):243-5. PubMed ID: 13255329
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of morbus haemolyticus neonatorum].
    WOLFF J
    Ther Ggw; 1952 Oct; 91(10):361-5. PubMed ID: 13029063
    [No Abstract]   [Full Text] [Related]  

  • 26. Practical management of erythroblastosis fetalis in a community hospital.
    ADELMAN M; BELL DW; GIUNTA F; BARRETT JT; BELLIN LB; APPLETON R
    J Am Med Assoc; 1959 Feb; 169(8):825-33. PubMed ID: 13620541
    [No Abstract]   [Full Text] [Related]  

  • 27. [Further fate of children born with serologic incompatibility].
    JERZYKOWSKA-KULESZYNA K
    Pediatr Pol; 1955 Oct; 30(10):905-12. PubMed ID: 13289181
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cortisone in the treatment and prevention of hemolytic disease in newborn; preliminary communication and report of four cases].
    LINARES GARZON H
    Prensa Med Argent; 1952 Feb; 39(8):340-51. PubMed ID: 14929874
    [No Abstract]   [Full Text] [Related]  

  • 29. [Considerations on 20 cases of hemolytic disease of the newborn treated by Rh negative blood transfusions].
    REVOL L; VIALLET H
    Lyon Med; 1949 Aug; 182(32):97. PubMed ID: 18139637
    [No Abstract]   [Full Text] [Related]  

  • 30. [Follow-up examinations and epicritical considerations of our newborn infants with fetal erythroblastosis treated in the period from 1947 to 1957].
    LAU H; PFAU P
    Med Welt; 1960 Oct; 41():2139-46. PubMed ID: 13759399
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the exsanguinotransfusion in newborn with heparinized fresh blood].
    GUIMBRETIERE J; HAROUSSEAU H; DELAROCHE Y; HEILMANN EM
    Munch Med Wochenschr; 1959 Jul; 101():1297-301. PubMed ID: 13830209
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy and results in fetal erythroblastosis].
    KINTZEL HW
    Dtsch Gesundheitsw; 1957 May; 12(19):584-7. PubMed ID: 13447474
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cortisone in the treatment of hemolytic disease caused by Rh factor; case report].
    MONNET P
    Pediatrie; 1956; 11(3):348-50. PubMed ID: 13349354
    [No Abstract]   [Full Text] [Related]  

  • 34. [Present state of fetal erythroblastosis].
    GOMEZ DURAN A; PICAZO GUILLEN J
    Med Cir Guerra; 1955; 17(7-8):451-6. PubMed ID: 13287538
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of the treatment of fetal erythroblastosis].
    VAN DEN BROUCKE C; VAN DEN BOSCH ; GELDERS NH
    Brux Med; 1953 May; 33(21):1082-91. PubMed ID: 13082159
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of erythroblastosis fetalis].
    MEDINA AGUILAR RA
    Rev Asoc Medica Mex; 1952 Jan; 32(644):25-34. PubMed ID: 14928982
    [No Abstract]   [Full Text] [Related]  

  • 37. [The significance of exchange transfusion in the therapy of fetal erythroblastosis due to Rhesus antagonism].
    HOYNCK VAN PAPENDRECHT HP; HART PG
    Ned Tijdschr Geneeskd; 1962 Jun; 106():1134-8. PubMed ID: 14449438
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment by exsanguino-transfusion of the newborn with haemytic disease].
    BUHOT S
    Sem Hop; 1949 Sep; 25(71):2913-20. PubMed ID: 18143782
    [No Abstract]   [Full Text] [Related]  

  • 39. The changing pattern of haemolytic disease of the newborn (1948-1957).
    WALKER W
    Vox Sang; 1958 Sep; 3(5):336-54. PubMed ID: 13604119
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of erythroblastosis fetalis.
    SNELLING CE; DONOHUE WL; McKEE M
    Can Med Assoc J; 1952 Apr; 66(4):356-9. PubMed ID: 14916377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.